PATIENT_ID	HISTOLOGY	AGE_CURRENT	SEX	SMOKING_HISTORY	SMOKER_PACK_YEARS	PDL1_EXPRESSION	PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY	DOSAGE	TREATMENT_SCHEDULE	PFS_MONTHS	PFS_STATUS	OVERALL_RESPONSE	DURABLE_CLINICAL_BENEFIT	NONSYNONYMOUS_MUTATION_BURDEN	MOLECULAR_SMOKING_SIGNATURE	NEOANTIGEN_BURDEN	TOTAL_EXONIC_MUTATION_BURDEN
HE3202	Adenocarcinoma	63	Female	Former	58.0	Strong	3	10	3	14.7	0:Censure	Partial Response	DCB	746	Transversion High	610	1011
TU0428	Adenocarcinoma	66	Male	Current	48.0	Negative	0	10	3	2.1	1:Event	Progression of Disease	NDB	626	Transversion High	446	992
RI1933	Adenocarcinoma	60	Female	Former	21.0	Strong	1	10	3	16.6	0:Censure	Partial Response	DCB	473	Transversion High	228	622
CA9903	Adenocarcinoma	57	Male	Former	80.0	Strong	3	10	3	14.5	1:Event	Partial Response	DCB	324	Transversion High	226	494
KA3947	Adenocarcinoma	64	Female	Former	52.5	Strong	0	10	3	8.1	1:Event	Stable Response	DCB	302	Transversion High	114	426
SC0899	Adenocarcinoma	64	Female	Current	25.0	Weak	0	10	3	12.6	0:Censure	Partial Response	DCB	296	Transversion High	191	450
MA7027	Adenocarcinoma	56	Male	Former	37.5	Weak	1	10	2	1.8	1:Event	Progression of Disease	NDB	292	Transversion High	90	396
DI6359	Adenocarcinoma	61	Female	Current	60.0	Strong	6	10	3	9.8	0:Censure	Partial Response	DCB	228	Transversion High	215	326
JB112852	Adenocarcinoma	60	Male	Never	0.0	Negative	5	10	2	3.3	1:Event	Progression of Disease	NDB	190	Transversion Low	118	341
SC6470	Adenocarcinoma	59	Male	Current	15.0	Weak	0	10	2	8.3	1:Event	Stable Response	DCB	185	Transversion High	100	292
GR4788	Squamous cell Carcinoma	59	Male	Current	45.0	Negative	0	10	2	1.9	1:Event	Progression of Disease	NDB	170	Transversion High	51	255
BL3403	Adenocarcinoma	73	Female	Former	43.75	Weak	1	10	2	6.5	1:Event	Stable Response	NDB	148	Transversion Low	99	261
RO3338	Adenocarcinoma	71	Male	Former	20.0	Weak	1	10	3	2.1	1:Event	Progression of Disease	NDB	106	Transversion Low	112	167
AU5884	Adenocarcinoma	64	Male	Former	10.0	Weak	2	10	2	1.8	1:Event	Progression of Disease	NDB	34	Transversion Low	27	80
VA1330	Adenocarcinoma	71	Female	Former	0.5	Unknown	1	10	3	4.1	1:Event	Stable Response	NDB	22	Transversion Low	11	88
VA7859	Adenocarcinoma	57	Female	Former	3.15	Unknown	1	10	3	6.3	1:Event	Stable Response	NDB	11	Transversion Low	8	45
